855.846.6529 tmiles@timmileslaw.com

NEWS PROVIDED BY Law Offices Of Timothy L. Miles October 04, 2020

Timothy L. Miles, a nationally recognized shareholder rights attorney

Odonate Shareholder Files Class Action Against Company for Misleading Shareholders; Odonate Shareholder Urged to Contact the Law Offices of Timothy L. Miles

Odonate Therapeutics, Inc. (NASDAQ:ODT)HENDERSONVILLE, TN, UNITED STATES, October 4, 2020 /EINPresswire.com/ — HENDERSONVILLE, TN / October 4, 2020/ The Law Offices of Timothy L. Miles, who has been leading the fight to protect shareholder rights for over 19 years, announces that a purchaser of securities of Odonate Therapeutics, Inc. (NASDAQ: ODT) has filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between December 7, 2017 and August 21, 2020. The case is captioned Kendall v. Odonate Therapeutics Inc., No. 20-cv-01828 (S.D. Ca.), and is assigned to Judge Marilyn Huff. Based in San Diego, California, Odonate is a pharmaceutical company that develops therapeutics for the treatment of cancer. The Company is developing tesetaxel, an oral chemotherapy.

Odonate Therapeutics, Inc. (ODT) Accused of Misrepresenting Potential of New Cancer Drug

According to the complaint, during the relevant period, Odonate Therapeutics, Inc. touted the extent of its clinical trials of tesetaxel and the efficacy of the drug. Unbeknownst to shareholders, Odonate Therapeutics failed to disclose the serious safety and tolerance issues surrounding tesetaxel, which has compromised the drug’s potential commercial viability as a cancer treatment. Before market hours on August 24, 2020, Odonate released its CONTESSA trial results, shocking investors with the announcement that tesetaxel substantially increased neutropenia (low white blood cell counts), neuropathy, and other adverse events. The trial results demonstrated a discontinuation rate of just 11.9% in the control group versus 23.1% in the tesetaxel treatment group. On this news, Odonate stock price fell 43.35% to close at $18.33 per share on August 24, 2020.

If you purchased Odonate Therapeutics, Inc. (ODT) securities between December 7, 2017 and August 21, 2020, you have until November 16, 2020, to ask the court to appoint you lead plaintiff for the class.

Odonate Shareholders Urged to Contact the Firm

If you purchased Odonate securities, have information, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Timothy L. Miles, Esquire, at 615-587-7384, Toll-Free at 855-846-6529, or by email to tmiles@timmileslaw.com. If you inquire by email please include your mailing address, telephone number, and the number shares owned.

About Timothy L. Miles

Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles was recentely awarded the recognition of American’s Most Honored Lawyers 2020 – Top 1% by the American Registry. Mr. Miles was also recently selected by Martindale-Hubbell® and ALM as a 2020 Top Ranked Lawyer and a 2020 Top Rated Litigator. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Awards: Top Rated Litigator by Martindale-Hubbell® and ALM (2019); 2019 Elite Lawyer of The South by Martindale-Hubbell® and ALM (2019); Member of the Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association (2017-2019); AV® Preeminent™ Rating by Martindale-Hubble® (2014-2020); PRR AV Preeminent Rating on Lawyers.com (2018-2020); The Top-Rated Lawyer in Litigation™ for Ethical Standards and Legal Ability (Martindale-Hubble® 2015); Lifetime Achievement Award by Premier Lawyers of America (2019); Superb Rated Attorney (Avvo); Avvo Top Rated Lawyer for (Avvo 2017-2020). Mr. Miles has authored numerous publications advocating for shareholdings including most recently: Free Portfolio Monitoring Services Offered by Plaintiff Securities Firms Provides Significant Benefits To Investors (Timothy L. Miles, Dec. 3, 2019).

Contact:
Timothy L. Miles, Esq.
Law Offices of Timothy L. Miles
124 Shiloh Ridge
Hendersonville, TN 37075
Telephone: (855-846-6529)
Email: tmiles@timmileslaw.com Website: www.timmileslaw.com
SOURCE: The Law Offices of Timothy L. Miles

Timothy Lee. Miles
Law Offices Of Timothy L. Miles
+1 615-587-7384
email us here

Nationally Recognized Shareholder Rights Attorney Timothy L. Miles Has Achieved the Recognition of American’s Most Honored Lawyers 2020 – Top 1%